Gene: NDUFAF4
Official Full Name: NADH:ubiquinone oxidoreductase complex assembly factor 4provided by HGNC
Gene Summary: NADH:ubiquinone oxidoreductase (complex I) catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q) in the first step of the mitochondrial respiratory chain, resulting in the translocation of protons across the inner mitochondrial membrane. This gene encodes a complex I assembly factor. Mutations in this gene are a cause of mitochondrial complex I deficiency. [provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27197 | NDUFAF4 Knockout cell line (HeLa) | Human | NDUFAF4 | 1:3~1:6 | Negative | Online Inquiry |
KO27198 | NDUFAF4 Knockout cell line (HCT 116) | Human | NDUFAF4 | 1:2~1:4 | Negative | Online Inquiry |
KO27199 | NDUFAF4 Knockout cell line (HEK293) | Human | NDUFAF4 | 1:3~1:6 | Negative | Online Inquiry |
NDUFAF4 Gene Knockout Cell Lines are specialized cell lines engineered for the targeted disruption of the NDUFAF4 gene, which encodes a crucial protein in the mitochondrial respiratory chain complex I assembly. This knockout technology facilitates detailed investigations into the gene's role in cellular metabolism, mitochondrial function, and broader implications in pathological conditions such as neurodegenerative diseases, cancer, and metabolic disorders.
The key function of these cell lines lies in their ability to model gene-specific outcomes, allowing researchers to observe the phenotypic effects of NDUFAF4 disruption. This is accomplished through sophisticated techniques such as CRISPR/Cas9 gene editing, which ensures precise, heritable modifications that effectively eliminate the gene's expression. With these cell lines, researchers can accurately assess mitochondrial dysfunction and energy metabolism alterations that stem from NDUFAF4 knockout, providing insights into mechanisms underlying various diseases.
The scientific importance of NDUFAF4 Gene Knockout Cell Lines is underscored by their varied applications in both research and clinical settings. They serve as invaluable tools for elucidating the biochemical pathways involved in mitochondrial biogenesis and fusion, studying disease mechanisms, and evaluating potential therapeutic targets. In cancer research, for instance, these cell lines can help identify how disruptions in mitochondrial function may contribute to tumorigenesis or metastasis.
Compared to alternative gene manipulation methodologies, the NDUFAF4 Gene Knockout Cell Lines offer enhanced specificity and efficiency, reducing off-target effects that could obscure experimental results. Additionally, their ease of use and reproducibility make them favorable options for labs looking to conduct high-throughput screens or work in diverse experimental conditions.
For researchers and clinicians focused on advancing our understanding of mitochondrial diseases, these knockout cell lines represent a critical resource. They not only expedite the discovery of novel pathways and drug candidates but also enhance the ability to develop targeted interventions tailored to the intricacies of mitochondrial dysfunction.
With a longstanding commitment to advancing cellular biology and genetic research, our company specializes in providing high-quality, reliable biological products like the NDUFAF4 Gene Knockout Cell Lines, positioning ourselves as a trusted partner in scientific innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.